Company intelligence / Profile preview

Exigent Research

United States

Ownership: Private
Development stage: Other

Overview

Exigent Research is a national network of independent oncology practices designed to accelerate and democratize access to clinical cancer research in community settings, enabling rapid patient enrollment and matching through proprietary and partner technologies, with demonstrated rapid trial activations and consents in partnership with AI-driven platforms.

Therapeutic areas: Oncology
Industry: Contract Research Organization

Partnerships

BostonGene (AI-driven molecular and immune profiling partnership for the BEGIN study)Tempus (integration with Tempus AI TIME program for patient-trial matching)

Beyond the preview

Go deeper on Exigent Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Exigent Research.

Explore the full profile